Abstract
The discovery of a case of disseminated anergic cutaneous leishmaniasis endogenous to Texas and the Mexican states of Tamaulipas and Nuevo Leon is of epidemiologic importance. An acquired or genetically determined defect in the immune or inflammatory systems of the patients who develop this rare form of leishmaniasis is postulated. No initial clinical response was obtained from treatment with cycloguanil pamoate (Camolar).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
